13-48465046-G-C
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_000321.3(RB1):c.2260G>C(p.Val754Leu) variant causes a missense change. The variant allele was found at a frequency of 0.00000074 in 1,350,728 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_000321.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RB1 | NM_000321.3 | c.2260G>C | p.Val754Leu | missense_variant | Exon 22 of 27 | ENST00000267163.6 | NP_000312.2 | |
RB1 | NM_001407165.1 | c.2260G>C | p.Val754Leu | missense_variant | Exon 22 of 27 | NP_001394094.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RB1 | ENST00000267163.6 | c.2260G>C | p.Val754Leu | missense_variant | Exon 22 of 27 | 1 | NM_000321.3 | ENSP00000267163.4 | ||
RB1 | ENST00000650461.1 | c.2260G>C | p.Val754Leu | missense_variant | Exon 22 of 27 | ENSP00000497193.1 | ||||
RB1 | ENST00000643064.1 | c.192+83603G>C | intron_variant | Intron 1 of 1 | ENSP00000496005.1 |
Frequencies
GnomAD3 genomes Cov.: 28
GnomAD4 exome AF: 7.40e-7 AC: 1AN: 1350728Hom.: 0 Cov.: 36 AF XY: 0.00000149 AC XY: 1AN XY: 670438
GnomAD4 genome Cov.: 28
ClinVar
Submissions by phenotype
Retinoblastoma Uncertain:2
This missense variant replaces valine with leucine at codon 754 of the RB1 protein. Computational prediction is inconclusive regarding the impact of this variant on protein structure and function (internally defined REVEL score threshold 0.5 < inconclusive < 0.7, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant (same amino acid change, different nucleotide change) has been reported in individuals affected with retinoblastoma (PMID: 34456592). This variant has not been identified in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. -
This sequence change replaces valine, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 754 of the RB1 protein (p.Val754Leu). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with RB1-related conditions. ClinVar contains an entry for this variant (Variation ID: 135124). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on RB1 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
not provided Uncertain:2
Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant does not alter protein structure/function; Observed in individuals with unilateral retinoblastoma and no relevant family history, as well as healthy individuals undergoing whole genome sequencing (Bodian et al., 2014; Xie et al., 2021); This variant is associated with the following publications: (PMID: 24728327, 34456592) -
The RB1 c.2260G>C; p.Val754Leu variant (rs587778642), to our knowledge, is not reported in the medical literature in individuals affected with an RB1-related condition but is reported in ClinVar (Variation ID: 135124). This variant is absent from the Genome Aggregation Database (v2.1.1), indicating it is not a common polymorphism. Computational analyses are uncertain whether this variant is neutral or deleterious (REVEL: 0.551). Due to limited information, the clinical significance of this variant is uncertain at this time. -
Hereditary cancer-predisposing syndrome Uncertain:1
The p.V754L variant (also known as c.2260G>C), located in coding exon 22 of the RB1 gene, results from a G to C substitution at nucleotide position 2260. The valine at codon 754 is replaced by leucine, an amino acid with highly similar properties. This amino acid position is well conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
not specified Other:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at